Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index
CALLAGY, Grace M, PHAROAH, Paul D, FINDER, Sarah E, HSU, Forrest D, NIELSEN, Torsten O, RAGAZ, Joseph, ELLIS, Ian O, HUNTSMAN, David, CALDAS, Carlos
Published in Clinical cancer research (15.04.2006)
Published in Clinical cancer research (15.04.2006)
Get full text
Journal Article
Abstract P6-05-09: Subtyping of triple negative breast cancer by a novel immunohistochemistry panel: Assessing the correlation between subtypes and clinical outcomes
Walsh, EM, Shalaby, A, Murillo, LS, Webber, MJ, Kerin, MJ, Glynn, SA, Callagy, GM, Ingoldsby, H, Keane, MM
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease
Inderhaug, CR, Murillo, LS, Webber, MJ, Callagy, GM
Published in Breast cancer research : BCR (23.06.2009)
Published in Breast cancer research : BCR (23.06.2009)
Get full text
Journal Article
A recurrent chromosome breakpoint in breast cancer at the NRG1/Neuregulin 1/Heregulin gene
HUANG, Huai-En, CHIN, Suet-Feung, GULLICK, William J, JACQUEMIER, Jocelyne, CALDAS, Carlos, CHAFFANET, Max, BIRNBAUM, Daniel, EDWARDS, Paul A. W, GINESTIER, Christophe, BARDOU, Valérie-Jeanne, ADELAÏDE, José, GOPALAKRISHNA IYER, N, GARCIA, Maria J, POLE, Jessica C, CALLAGY, Grace M, HEWITT, Stephen M
Published in Cancer research (Chicago, Ill.) (01.10.2004)
Published in Cancer research (Chicago, Ill.) (01.10.2004)
Get full text
Journal Article